Delivery Order SPE2DB22D2006-SPE2DB24FV8JQ

Award Date 2/24/24
Potential Completion Date 2/26/24
Potential Value $5.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $14,686.48, is for the delivery of LUPRON DEPOT 22.5 MG 3MO KITS, a specialty pharmaceutical product. The contract is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999.00 and running...
This federal contract award, valued at $61,322.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS, a specialty pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $13,099.63 firm fixed-price delivery order is for the supply of Lupron Depot 3.75 mg kits, a pharmaceutical product used in various medical treatments. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $13,618.26, is for the supply of LUPRON DEPOT 11.25 MG 3MO KITS, a specialty pharmaceutical product. This contract supports the medical needs of military personnel, veterans, and other federal beneficiaries. The contract does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $6,064.36 delivery order contract is for the supply of Lupron Depot 3.75 mg kits, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 19, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support...
This federal contract award, valued at $10,243.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS, a specialty medication used in various medical treatments. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $76,959.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUPRON DEPOT 11.25 MG 3MO KITS, a specialty pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,581.60 firm fixed price delivery order is for 4565265156 LUPRON DEPOT 3.75 MG KITS, with a completion date of July 29, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award with ID SPE2DB22D1106|SPE2DB24FERB3 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,740.24 firm fixed-price delivery order is for the supply of LUPRON DEPOT 3.75 MG KITS, a pharmaceutical product, with a completion date of May 10, 2024. The award is not designated as a set-aside and appears to be a part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $57,032.76 for the pharmaceutical product LUPRON DEPOT 11.25 MG 3MO KITS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that supports the Department of Defense (DoD) and other federal healthcare programs. The contract has a firm fixed price and an ultimate completion date of December 15, 2022. It is not designated as a set-aside contract,...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FV8JQ
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,195.70 firm fixed-price delivery order is for the supply of LUPRON DEPOT 22.5 MG 3MO KITS, a specialty medication, to support military healthcare programs.

The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense worldwide. This IDC, which runs through November 2026, enables the efficient procurement of critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract award was made through full and open competition without any set-aside designations.

Generated 5/14/25, 10:25 AM